• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Improved Utilization of Serial Testing Without Increased Admissions after Implementation of High-Sensitivity Troponin I: a Controlled Retrospective Cohort Study.高敏肌钙蛋白 I 实施后,连续检测的利用率提高而住院人数未增加:一项基于对照的回顾性队列研究。
J Gen Intern Med. 2024 Apr;39(5):739-746. doi: 10.1007/s11606-023-08535-3. Epub 2023 Nov 22.
2
Effect of transitioning from conventional cardiac troponin to high-sensitivity cardiac troponin on resource utilization- a single center experience.从常规心肌肌钙蛋白向高敏心肌肌钙蛋白转换对资源利用的影响——一项单中心经验。
Am J Emerg Med. 2024 Jun;80:174-177. doi: 10.1016/j.ajem.2024.04.007. Epub 2024 Apr 11.
3
Impact of high-sensitivity cardiac troponin implementation on emergency department length of stay, testing, admissions, and diagnoses.高敏心肌肌钙蛋白检测实施对急诊科停留时间、检查、入院和诊断的影响。
Am J Emerg Med. 2021 Jul;45:54-60. doi: 10.1016/j.ajem.2021.02.021. Epub 2021 Feb 19.
4
Diagnostic accuracy of a machine learning algorithm using point-of-care high-sensitivity cardiac troponin I for rapid rule-out of myocardial infarction: a retrospective study.使用即时检测高敏心肌肌钙蛋白I的机器学习算法对心肌梗死进行快速排除诊断的准确性:一项回顾性研究。
Lancet Digit Health. 2024 Oct;6(10):e729-e738. doi: 10.1016/S2589-7500(24)00191-2. Epub 2024 Aug 29.
5
A Multicenter Assessment of the Sensitivity and Specificity for a Single High-Sensitivity Cardiac Troponin Test at Emergency Department Presentation for Hospital Admission.一项针对急诊科因住院而就诊时单次高敏肌钙蛋白检测的敏感性和特异性的多中心评估。
J Appl Lab Med. 2019 Sep;4(2):170-179. doi: 10.1373/jalm.2019.029512. Epub 2019 Jul 31.
6
A multicentre, randomized, controlled open-label trial to compare an Accelerated Rule-Out protocol using combined prehospital copeptin and in-hospital high sensitive troponin with standard rule-out in patients suspected of acute Myocardial Infarction - the AROMI trial.一项多中心、随机、对照开放标签试验,旨在比较在疑似急性心肌梗死患者中使用院前 copeptin 和院内高敏肌钙蛋白联合的加速排除方案与标准排除方案——AROMI 试验。
Trials. 2018 Dec 12;19(1):683. doi: 10.1186/s13063-018-2990-z.
7
Association of a Novel Protocol for Rapid Exclusion of Myocardial Infarction With Resource Use in a US Safety Net Hospital.一种新的快速排除心肌梗死的方案与美国安全网医院资源利用的关联。
JAMA Netw Open. 2020 Apr 1;3(4):e203359. doi: 10.1001/jamanetworkopen.2020.3359.
8
Single vs Serial Measurements of Cardiac Troponin Level in the Evaluation of Patients in the Emergency Department With Suspected Acute Myocardial Infarction.单一与连续测量心脏肌钙蛋白水平在急诊科疑似急性心肌梗死患者评估中的比较。
JAMA Netw Open. 2021 Feb 1;4(2):e2037930. doi: 10.1001/jamanetworkopen.2020.37930.
9
Introduction of a high sensitivity troponin reduces ED length of stay.高敏肌钙蛋白的引入降低了 ED 住院时间。
Am J Emerg Med. 2024 Feb;76:82-86. doi: 10.1016/j.ajem.2023.11.028. Epub 2023 Nov 21.
10
Clinical impact of a high-sensitivity troponin assay introduction on patients presenting to the emergency department.高敏肌钙蛋白检测方法的引入对急诊科患者的临床影响。
Emerg Med Australas. 2016 Jun;28(3):273-8. doi: 10.1111/1742-6723.12566. Epub 2016 Mar 16.

本文引用的文献

1
High-Sensitivity Cardiac Troponin Algorithms and the Value of Likelihood Ratios.高敏心肌肌钙蛋白算法与似然比的价值。
J Gen Intern Med. 2023 Jul;38(9):2189-2193. doi: 10.1007/s11606-023-08103-9. Epub 2023 Mar 7.
2
Implementation of High-Sensitivity Cardiac Troponin Assays in the United States.美国高敏心肌肌钙蛋白检测的应用。
J Am Coll Cardiol. 2023 Jan 24;81(3):207-219. doi: 10.1016/j.jacc.2022.10.017. Epub 2022 Oct 31.
3
Cost-effectiveness of a rule-out algorithm of acute myocardial infarction in low-risk patients: emergency primary care versus hospital setting.低危急性心肌梗死患者排除算法的成本效益:急救初级保健与医院环境的比较。
BMC Health Serv Res. 2022 Oct 21;22(1):1274. doi: 10.1186/s12913-022-08697-6.
4
2022 ACC Expert Consensus Decision Pathway on the Evaluation and Disposition of Acute Chest Pain in the Emergency Department: A Report of the American College of Cardiology Solution Set Oversight Committee.2022年美国心脏病学会急诊室急性胸痛评估与处置专家共识决策路径:美国心脏病学会解决方案集监督委员会报告
J Am Coll Cardiol. 2022 Nov 15;80(20):1925-1960. doi: 10.1016/j.jacc.2022.08.750. Epub 2022 Oct 11.
5
High-Sensitivity Cardiac Troponin and the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guidelines for the Evaluation and Diagnosis of Acute Chest Pain.高敏心肌肌钙蛋白与 2021 年 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR 急性胸痛评估与诊断指南。
Circulation. 2022 Aug 16;146(7):569-581. doi: 10.1161/CIRCULATIONAHA.122.059678. Epub 2022 Jul 1.
6
Impact of a rapid high-sensitivity troponin pathway on patient flow in an urban emergency department.快速高敏肌钙蛋白检测流程对城市急诊科患者流程的影响
J Am Coll Emerg Physicians Open. 2022 May 5;3(3):e12739. doi: 10.1002/emp2.12739. eCollection 2022 Jun.
7
Outcomes Associated with Introduction of the 5 Generation High-Sensitivity Cardiac Troponin in Patients Presenting with Cardiovascular Disorders.与心血管疾病患者中引入第 5 代高敏心肌肌钙蛋白相关的结果。
J Emerg Med. 2022 May;62(5):657-667. doi: 10.1016/j.jemermed.2022.01.011. Epub 2022 Apr 2.
8
Emergency Department Management of Chest Pain With a High-Sensitivity Troponin-Enabled 0/1-Hour Rule-Out Algorithm.高敏肌钙蛋白启用的 0/1 小时排除算法在胸痛急诊科管理中的应用。
Am J Clin Pathol. 2022 May 4;157(5):774-780. doi: 10.1093/ajcp/aqab192.
9
Implementation of more sensitive cardiac troponin T assay in a state-wide health service.在全州卫生服务中实施更敏感的心肌肌钙蛋白 T 检测。
Int J Cardiol. 2022 Jan 15;347:66-72. doi: 10.1016/j.ijcard.2021.11.013. Epub 2021 Nov 11.
10
2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR 胸痛评估与诊断指南:美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
Circulation. 2021 Nov 30;144(22):e368-e454. doi: 10.1161/CIR.0000000000001029. Epub 2021 Oct 28.

高敏肌钙蛋白 I 实施后,连续检测的利用率提高而住院人数未增加:一项基于对照的回顾性队列研究。

Improved Utilization of Serial Testing Without Increased Admissions after Implementation of High-Sensitivity Troponin I: a Controlled Retrospective Cohort Study.

机构信息

Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.

Weill Department of Medicine, Weill Cornell Medicine, New York, NY, USA.

出版信息

J Gen Intern Med. 2024 Apr;39(5):739-746. doi: 10.1007/s11606-023-08535-3. Epub 2023 Nov 22.

DOI:10.1007/s11606-023-08535-3
PMID:37993739
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11043247/
Abstract

BACKGROUND

Guidelines recommend high-sensitivity cardiac troponin (hs-cTn) for diagnosis of myocardial infarction. Use of hs-cTn is increasing across the U.S., but questions remain regarding clinical and operational impact. Prior studies have had methodologic limitations and yielded conflicting results.

OBJECTIVE

To evaluate the impact of transitioning from conventional cardiac troponin (cTn) to hs-cTn on test and resource utilization, operational efficiency, and patient safety.

DESIGN

Retrospective cohort study in two New York City hospitals during the months before and after transition from conventional cTn to hs-cTn at Hospital 1. Hospital 2 served as a control.

PARTICIPANTS

Consecutive emergency department (ED) patients with at least one cTn test resulted.

INTERVENTION

Multifaceted hs-cTn intervention bundle, including a 0/2-h diagnostic algorithm for non-ST-elevation myocardial infarction, an educational bundle, enhancements to the electronic medical record, and nursing interventions to facilitate timed sample collection.

MAIN MEASURES

Primary outcomes included serial cTn test utilization, probability of hospital admission, ED length of stay (LOS), and among discharged patients, probability of ED revisit within 72 h resulting in hospital admission. Multivariable regression models adjusted for age, sex, temporal trends, and interhospital differences.

KEY RESULTS

The intervention was associated with increased use of serial cTn testing (adjusted risk difference: 48 percentage points, 95% CI: 45-50, P < 0.001) and ED LOS (adjusted geometric mean difference: 50 min, 95% CI: 50-51, P < 0.001). There was no significant association between the intervention and probability of admission (adjusted relative risk [aRR]: 0.99, 95% CI: 0.89-1.1, P = 0.81) or probability of ED revisit within 72 h resulting in admission (aRR: 1.1, 95% CI: 0.44-2.9, P = 0.81).

CONCLUSIONS

Implementation of a hs-cTn intervention bundle was associated with an improvement in serial cTn testing, a neutral effect on probability of hospital admission, and a modest increase in ED LOS.

摘要

背景

指南建议使用高敏心肌肌钙蛋白(hs-cTn)进行心肌梗死的诊断。hs-cTn 在全美范围内的应用正在增加,但关于其对临床和运营的影响仍存在疑问。先前的研究存在方法学上的局限性,得出的结果也相互矛盾。

目的

评估从常规心肌肌钙蛋白(cTn)向 hs-cTn 过渡对检验和资源利用、运营效率以及患者安全的影响。

设计

在纽约市两家医院进行的回顾性队列研究,一家医院(医院 1)在从常规 cTn 向 hs-cTn 过渡前后的几个月内进行,另一家医院(医院 2)作为对照。

参与者

至少进行过一次 cTn 检测的连续急诊部(ED)患者。

干预措施

hs-cTn 综合干预包,包括非 ST 段抬高型心肌梗死的 0/2 小时诊断算法、教育包、电子病历增强功能以及护理干预以促进定时样本采集。

主要观察指标

主要结局包括连续 cTn 检测的使用、住院概率、ED 住院时间(LOS)以及出院患者在 72 小时内因 ED 复诊而再次入院的概率。多变量回归模型调整了年龄、性别、时间趋势和医院间差异。

主要结果

干预措施与连续 cTn 检测的使用增加相关(调整风险差异:48 个百分点,95%置信区间:45-50,P<0.001)和 ED LOS 增加相关(调整后的几何均数差异:50 分钟,95%置信区间:50-51,P<0.001)。干预措施与入院概率之间无显著关联(调整后的相对风险[aRR]:0.99,95%置信区间:0.89-1.1,P=0.81)或在 72 小时内因 ED 复诊而再次入院的概率(aRR:1.1,95%置信区间:0.44-2.9,P=0.81)。

结论

实施 hs-cTn 干预包与连续 cTn 检测的改善相关,对入院概率无显著影响,ED LOS 略有增加。